Atlas Trials

Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia

Clinical trial NCT00688896 · COMPLETED

Trial details

NCT number
NCT00688896
Sponsor
Akros Pharma Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type II Hyperlipidemia
Start date
2002-06-01
Primary completion
2003-04-01
Enrollment
155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.